Prophylactic Administration of Neulapeg (Pegteograstim) in Patients With Locally Advanced or Metastatic Pancreatic Cancer Receiving the Modified FOLFIRINOX

Conditions: Locally Advanced Pancreatic Cancer; Metastatic Pancreatic Cancer Interventions: Drug: Neulapeg; Other: Control Sponsors: Yonsei University Active, not recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials